Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3-L1 adipocytes by inhibiting a negative control mechanism

This publication has 13 references indexed in Scilit:

• Hepatic insulin resistance in KKAy mice and its amelioration by pioglitazone do not involve alterations in phospholipase C activity
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
• The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains
  Diabetes, 1993
• Insulin Stimulates the Degradation of IRS-1 in 3T3-L1 Adipocytes
  Biochemical and Biophysical Research Communications, 1993
• Insulin Stimulates Phosphatidylinositol‐3‐Kinase activity in rat adipocytes
  European Journal of Biochemistry, 1992
• The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance
  Diabetologia, 1991
• Glucose Transport Deficiency in Diabetic Animals Is Corrected by Treatment with the Oral Antihyperglycemic Agent Pioglitazone*
  Endocrinology, 1991
• Phosphoinositide kinases
  Biochemistry, 1990
• Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice
  Diabetes, 1990
• Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes
  The American Journal of Medicine, 1988
• Ciglitazone reverses cAMP‐induced post‐insulin receptor resistance in rat adipocytes in vitro
  FEBS Letters, 1984